Project Grant S10OD034444
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $578,070 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to purchase a high-resolution portable photon counting computed tomography (CT) scanner. The equipment will be shared by researchers across the Departments of Anesthesia, Radiology, Neurosurgery, and Surgery at MGH and Boston Children's Hospital. The new CT...
- The Department of Health and Human Services National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $742,360 Project Grant (CFDA 93.351) to Oregon Health & Science University (OHSU) on July 15, 2025. The grant will be used to purchase a Vevo F2 LAZR-X dual ultrasound-photoacoustic imaging system to support and enhance current NIH-funded projects and promote innovative basic and translational research at OHSU and neighboring institutions. The advanced...
- This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $392,500 to Mainehealth, a non-profit healthcare system in Portland, Maine, to purchase a state-of-the-art Bruker SkyScan1276 CMOS micro-computed tomography (microCT) system. The new microCT system will replace Mainehealth's aging imaging equipment and enable the organization's Small Animal Imaging Facility to continue providing high-resolution imaging...
- This $923,205 federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable researchers at the University of Rochester and their collaborators to acquire a state-of-the-art Vevo F2 LZR-X ultrasound and photoacoustic imaging system. This advanced small animal imaging instrument will support a wide range of foundational and applied research projects across diverse disciplines at the university, including medicine,...
- This $1,658,828 Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will enable the acquisition of a Thermo Scientific Orbitrap Astral Mass Spectrometer for the Mass Spectrometry Facility & Proteomics Center at the Medical University of South Carolina (MUSC) in Charleston. This state-of-the-art mass spectrometry instrument will support NIH-funded research across numerous disease areas, including cancer, immunotherapy,...
- This $250,000 Project Grant award, provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351), will enable Montana State University Billings (MSUB) to acquire an Agilent 1290 Infinity Series II Ultra-High-Performance Liquid Chromatography (UHPLC) system integrated with an Agilent 6530 Quadrupole Time-of-Flight (QTOF) mass spectrometer. This cutting-edge analytical instrumentation will support advanced biomedical research and education at MSUB,...
- This Project Grant award of $418,835 from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) will support the purchase of a VevoF2 high-resolution research ultrasound imaging system for the Cardiovascular Phenotype Core at the University of Iowa. The new system will replace an obsolete Vevo 2100 instrument that has reached end-of-life, enabling the core to continue providing over 4,000 imaging studies per year in support of researchers across the...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of an ultrasound-coupled electrical impedance tomography (US-EIT) device for assessing sarcopenia, a condition involving loss of skeletal muscle mass and function. The $275,762 award to Rytek Medical Inc. will be used to design a sonolucent electrode array and housing that integrates with a standard ultrasound probe, enabling quantitative evaluation of muscle health through...
- This Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will provide $252,500 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a "Versatile High-Throughput Alinity CI Assay Platform" to support multiple laboratory animal users. The new assay platform will replace MGH's existing end-of-life Architect platform, which has been essential for conducting...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $263,749 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Sound Innovation LLC in Albany, NY. The grant supports the development of a portable small animal imager to accelerate drug development. The project aims to create a cost-effective and high-quality imaging solution to improve the preclinical stage of the drug development...
SHARED INSTRUMENTATION GRANT APPLICATION FOR ECHOMRI WHOLE BODY COMPOSITION ANALYZER - ABSTRACT: THIS PROPOSAL AIMS TO SECURE FUNDING FOR ACQUIRING A NEW GENERATION ECHOMRI WHOLE BODY COMPOSITION ANALYZER TO ADDRESS THE URGENT NEED FOR RELIABLE AND ADVANCED RESEARCH CAPABILITIES THAT ARE CRITICAL TO ENSURE UNINTERRUPTED PROGRESS AND ADVANCE OF FEDERALLY FUNDED PROJECTS AT OHSU. THE NEW ECHOMRI ANALYZER IS CAPABLE OF ACCURATE MEASUREMENTS OF WHOLE-BODY COMPOSITION IN SMALL LIVE ANIMALS, WHICH IS CRUCIAL FOR INVESTIGATING METABOLIC DISORDERS, MONITORING CHRONIC DISEASE PROGRESSION AND UNDERSTANDING DISEASE MECHANISMS OVER TIME, ESPECIALLY IN YOUNG ANIMALS AND DURING EARLY DEVELOPMENT. THE INSTRUMENT CURRENTLY AVAILABLE FOR OHSU RESEARCHERS IS 16 YEARS OLD, OBSOLETE IN BOTH HARDWARE AND SOFTWARE, PLAGUED BY FREQUENT AND UNPREDICTABLE MALFUNCTIONS, DWINDLING MANUFACTURER SUPPORT, AND INCOMPATIBLE TO UPGRADING. ITS INCREASINGLY FREQUENT BREAKDOWNS HAVE CAUSED SIGNIFICANT DISRUPTIONS, DELAYS AND DATA LOSS IN NIH-FUNDED STUDIES. THE REQUESTED NEW ANALYZER, WITH THE LATEST VERSIONS OF HARDWARE AND SOFTWARE AND ENHANCED CAPABILITIES,WILL NOT ONLY SOLVE THE PROBLEMOF UNPREDICTABLEUNAVAILABILITY, BUT WILL ALSO OFFER EXPANDED TEST MODALITIES, NEW MEASUREMENT CAPABILITIES, IMPROVED MEASUREMENT ACCURACY AND ENHANCED DATA SAFETY. IT WILL BE PROCURED FROM THE SAME VENDOR OF THE INSTRUMENT CURRENTLY USED AT OHSU, ECHOMRI LLC, WHICH CAN ENSURE A SEAMLESS TRANSITION. THE NEW ANALYZER WILL COST $136,650 AND WILL BE MANAGED BY THE OHSU UNIVERSITY SHARED RESOURCES (USR) PROGRAM, PROVIDING ACCESS TO AT LEAST NINE NIH-FUNDED RESEARCH GROUPS AND OTHER OHSU AFFILIATED INSTITUTIONS. WITH AN OPTIMIZED OPERATION AND MANAGEMENT TEAM IN PLACE, ACQUISITION OF THE NEW ECHOMRI ANALYZER WILL EMPOWER RESEARCHERS, FACILITATE BREAKTHROUGH DISCOVERIES, AND CONTRIBUTE TO SOLVING CRITICAL HEALTH ISSUES THROUGH INVESTIGATIONS ON METABOLIC AND ENDOCRINOLOGICAL PATHOGENESIS AND PATHOPHYSIOLOGIC MECHANISMS OF A BROAD RANGE OF CHRONIC DISEASES, OF WHICH COMPREHENSIVE BODY COMPOSITION ANALYSIS IS OFTEN AN INDISPENSABLE AND CRITICAL PART. THIS PROPOSED INVESTMENT HOLDS GREAT POTENTIAL FOR TRANSFORMATIVE IMPACTS ON RESEARCH OUTCOMES AND THE ADVANCEMENT OF EXCELLENCE IN BIOMEDICAL RESEARCH.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $136.7k | 5/2/24 |